Next-gen therapeutics to spare and expand beta-cell mass
Author:
Funder
European Foundation for the Study of Diabetes
Ministero della Salute
Fondazione Romeo ed Enrica Invernizzi
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference58 articles.
1. Regulation of pancreatic beta-cell mass;Bouwens;Physiol Rev,2005
2. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association;Insel;Diabetes Care,2015
3. Differentiation of diabetes by pathophysiology, natural history, and prognosis;Skyler;Diabetes,2017
4. A journey in diabetes: from clinical physiology to novel therapeutics: the 2020 banting medal for scientific achievement lecture;Ferrannini;Diabetes,2021
5. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021;Diabetes Care,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Elucidation of endothelial progenitor cell dysfunction in diabetes by RNA sequencing and constructing lncRNA–miRNA–mRNA competing endogenous RNA network;Journal of Molecular Medicine;2022-09-12
2. Benefits and Hurdles of Pancreatic β-Cell Replacement;Stem Cells Translational Medicine;2022-09-08
3. Editorial overview: ‘Caring for diabetes in its complexity: From targetable metabolic-organ crosstalk to novel drug interactions’;Current Opinion in Pharmacology;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3